Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Prioritization of novel druggable targets for epilepsy via Mendelian randomization and colocalization

Submitted by Anna Hakala on Wed, 02/18/2026 - 11:48
  • Read more about Prioritization of novel druggable targets for epilepsy via Mendelian randomization and colocalization

Intra-pancreatic fat deposition links to widespread systemic health risks: UK Biobank prospective cohort study

Submitted by Anna Hakala on Wed, 02/18/2026 - 11:44
  • Read more about Intra-pancreatic fat deposition links to widespread systemic health risks: UK Biobank prospective cohort study

Causality of atrial fibrillation and left atrial traits: Genetic and epigenetic perspectives

Submitted by Anna Hakala on Wed, 02/18/2026 - 11:42
  • Read more about Causality of atrial fibrillation and left atrial traits: Genetic and epigenetic perspectives

KLF4 orchestrates a Ccl2+ fibroblast-mediated inflammatory network driving preterm birth

Submitted by Anna Hakala on Wed, 02/18/2026 - 11:41
  • Read more about KLF4 orchestrates a Ccl2+ fibroblast-mediated inflammatory network driving preterm birth

Immunoproteomic mediators of diabetic peripheral neuropathy: causal insights from Mendelian randomization and single-cell validation

Submitted by Anna Hakala on Wed, 02/18/2026 - 11:39
  • Read more about Immunoproteomic mediators of diabetic peripheral neuropathy: causal insights from Mendelian randomization and single-cell validation

Integrative multi-omics analyses identify PKD1 and SLC2A4 as genetically supported glycolysis-related candidate genes for rheumatoid arthritis

Submitted by Anna Hakala on Wed, 02/18/2026 - 11:37
  • Read more about Integrative multi-omics analyses identify PKD1 and SLC2A4 as genetically supported glycolysis-related candidate genes for rheumatoid arthritis

Within- and Between-Family Validation of Nine Polygenic Risk Scores Developed in 1.5 Million Individuals: Implications for IVF, Embryo Selection, and Reduction in Lifetime Disease Risk

Submitted by Anna Hakala on Mon, 02/16/2026 - 13:15
  • Read more about Within- and Between-Family Validation of Nine Polygenic Risk Scores Developed in 1.5 Million Individuals: Implications for IVF, Embryo Selection, and Reduction in Lifetime Disease Risk

Genome-wide association study of corneal dystrophy uncovers novel risk loci and enables improved polygenic prediction of Fuchs endothelial corneal dystrophy

Submitted by Anna Hakala on Mon, 02/16/2026 - 13:13
  • Read more about Genome-wide association study of corneal dystrophy uncovers novel risk loci and enables improved polygenic prediction of Fuchs endothelial corneal dystrophy

Genomics link obesity and type 2 diabetes to Alzheimer’s disease to unveil novel biological insights

Submitted by Anna Hakala on Mon, 02/16/2026 - 13:12
  • Read more about Genomics link obesity and type 2 diabetes to Alzheimer’s disease to unveil novel biological insights

Lower mitochondrial DNA abundance in blood cells is associated with higher general morbidity and all-cause mortality: a 30-year prospective epidemiological study

Submitted by Anna Hakala on Mon, 02/16/2026 - 13:10
  • Read more about Lower mitochondrial DNA abundance in blood cells is associated with higher general morbidity and all-cause mortality: a 30-year prospective epidemiological study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Current page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement